Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Anderson

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Rheumatology|May 17, 2012
Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practiceKarim R Masri, Timothy S Shaver, Shadi H Shahouri, et al.
Arthritis and Rheumatism|July 9, 2011
Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteriaShadi H Shahouri, Kaleb Michaud, Ted R Mikuls, et al.
Molecular Cancer Therapeutics|November 18, 2003
Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3James D Anderson, Todd P Hansen, Paul W Lenkowski, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Rheumatology|May 17, 2012
Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practiceKarim R Masri, Timothy S Shaver, Shadi H Shahouri, et al.
Arthritis and Rheumatism|July 9, 2011
Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteriaShadi H Shahouri, Kaleb Michaud, Ted R Mikuls, et al.
Molecular Cancer Therapeutics|November 18, 2003
Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3James D Anderson, Todd P Hansen, Paul W Lenkowski, et al.
Pageof 3